{"entity":{"type":"insider","cik":"0001402652","url":"/insider/0001402652","json_url":"/insider/0001402652.json","name":"GRANDE ALICIA","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":34,"n_filings":15,"first":"2008-11-26","last":"2023-12-12","span_basis":"filed_date"},"name_variants":[{"name":"GRANDE ALICIA","source":"filing","n_filings":15,"first_seen":"2008-11-26","last_seen":"2023-12-12"}],"transactions":[{"id":8626399,"accession":"0001161697-23-000610","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001161697-23-000610","line_url":"/filing/0001161697-23-000610","is_derivative":false,"issuer_cik":"0001369568","issuer_name":"CATALYST PHARMACEUTICALS, INC.","issuer_ticker":"CPRX","issuer_name_source":null,"issuer_url":"/issuer/0001369568","owner_cik":"0001402652","owner_name":"GRANDE ALICIA","owner_display_name":"GRANDE ALICIA","owner_url":"/insider/0001402652","role":"Officer (VP, Treasurer and CFO)","role_mark":"O","role_mark_label":"Officer (VP, Treasurer and CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP, Treasurer and CFO","security_title":"Common Stock, par value $0.001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":60000.0,"shares_display":"60,000","price_per_share":13.763,"price_display":"13.76","price_state":"stated","total_value":825780.0,"total_display":"825,780.00","total_whole":"825,780","shares_owned_after":50557.0,"shares_owned_after_display":"50,557","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-12-11","filed_date":"2023-12-12","scope":"insider","n_lines":2},{"id":8626387,"accession":"0001161697-23-000610","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001161697-23-000610","line_url":"/filing/0001161697-23-000610","is_derivative":false,"issuer_cik":"0001369568","issuer_name":"CATALYST PHARMACEUTICALS, INC.","issuer_ticker":"CPRX","issuer_name_source":null,"issuer_url":"/issuer/0001369568","owner_cik":"0001402652","owner_name":"GRANDE ALICIA","owner_display_name":"GRANDE ALICIA","owner_url":"/insider/0001402652","role":"Officer (VP, Treasurer and CFO)","role_mark":"O","role_mark_label":"Officer (VP, Treasurer and CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP, Treasurer and CFO","security_title":"Common Stock, par value $0.001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":40000.0,"shares_display":"40,000","price_per_share":14.275,"price_display":"14.28","price_state":"stated","total_value":571000.0,"total_display":"571,000.00","total_whole":"571,000","shares_owned_after":50557.0,"shares_owned_after_display":"50,557","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-12-08","filed_date":"2023-12-12","scope":"insider","n_lines":2},{"id":7915966,"accession":"0001161697-23-000200","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0001161697-23-000200","line_url":"/filing/0001161697-23-000200","is_derivative":false,"issuer_cik":"0001369568","issuer_name":"CATALYST PHARMACEUTICALS, INC.","issuer_ticker":"CPRX","issuer_name_source":null,"issuer_url":"/issuer/0001369568","owner_cik":"0001402652","owner_name":"GRANDE ALICIA","owner_display_name":"GRANDE ALICIA","owner_url":"/insider/0001402652","role":"Officer (VP, Treasurer and CFO)","role_mark":"O","role_mark_label":"Officer (VP, Treasurer and CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP, Treasurer and CFO","security_title":"Common stock, par value $0.001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":50000.0,"shares_display":"50,000","price_per_share":16.702,"price_display":"16.70","price_state":"stated","total_value":835100.0,"total_display":"835,100.00","total_whole":"835,100","shares_owned_after":80557.0,"shares_owned_after_display":"80,557","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-03-29","filed_date":"2023-03-30","scope":"insider","n_lines":3},{"id":7915956,"accession":"0001161697-23-000200","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001161697-23-000200","line_url":"/filing/0001161697-23-000200","is_derivative":false,"issuer_cik":"0001369568","issuer_name":"CATALYST PHARMACEUTICALS, INC.","issuer_ticker":"CPRX","issuer_name_source":null,"issuer_url":"/issuer/0001369568","owner_cik":"0001402652","owner_name":"GRANDE ALICIA","owner_display_name":"GRANDE ALICIA","owner_url":"/insider/0001402652","role":"Officer (VP, Treasurer and CFO)","role_mark":"O","role_mark_label":"Officer (VP, Treasurer and CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP, Treasurer and CFO","security_title":"Common stock, par value $0.001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":58216.0,"shares_display":"58,216","price_per_share":16.538161330218497,"price_display":"16.54","price_state":"stated","total_value":962785.6,"total_display":"962,785.60","total_whole":"962,786","shares_owned_after":80557.0,"shares_owned_after_display":"80,557","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-03-28","filed_date":"2023-03-30","scope":"insider","n_lines":4},{"id":8361766,"accession":"0001161697-23-000185","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001161697-23-000185","line_url":"/filing/0001161697-23-000185","is_derivative":false,"issuer_cik":"0001369568","issuer_name":"CATALYST PHARMACEUTICALS, INC.","issuer_ticker":"CPRX","issuer_name_source":null,"issuer_url":"/issuer/0001369568","owner_cik":"0001402652","owner_name":"GRANDE ALICIA","owner_display_name":"GRANDE ALICIA","owner_url":"/insider/0001402652","role":"Officer (VP, Treasurer and CFO)","role_mark":"O","role_mark_label":"Officer (VP, Treasurer and CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP, Treasurer and CFO","security_title":"Common stock, par value $0.001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":41784.0,"shares_display":"41,784","price_per_share":16.50219797051503,"price_display":"16.50","price_state":"stated","total_value":689527.84,"total_display":"689,527.84","total_whole":"689,528","shares_owned_after":50557.0,"shares_owned_after_display":"50,557","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-03-22","filed_date":"2023-03-24","scope":"insider","n_lines":2},{"id":6621290,"accession":"0001161697-22-000562","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001161697-22-000562","line_url":"/filing/0001161697-22-000562#line-1","is_derivative":false,"issuer_cik":"0001369568","issuer_name":"CATALYST PHARMACEUTICALS, INC.","issuer_ticker":"CPRX","issuer_name_source":null,"issuer_url":"/issuer/0001369568","owner_cik":"0001402652","owner_name":"GRANDE ALICIA","owner_display_name":"GRANDE ALICIA","owner_url":"/insider/0001402652","role":"Officer (VP, Treasurer and CFO)","role_mark":"O","role_mark_label":"Officer (VP, Treasurer and CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP, Treasurer and CFO","security_title":"Common Stock, par value $0.001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":120000.0,"shares_display":"120,000","price_per_share":16.527,"price_display":"16.53","price_state":"stated","total_value":1983240.0,"total_display":"1,983,240.00","total_whole":"1,983,240","shares_owned_after":27442.0,"shares_owned_after_display":"27,442","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-11-22","filed_date":"2022-11-23","scope":"insider"},{"id":6293414,"accession":"0001161697-22-000553","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001161697-22-000553","line_url":"/filing/0001161697-22-000553#line-1","is_derivative":false,"issuer_cik":"0001369568","issuer_name":"CATALYST PHARMACEUTICALS, INC.","issuer_ticker":"CPRX","issuer_name_source":null,"issuer_url":"/issuer/0001369568","owner_cik":"0001402652","owner_name":"GRANDE ALICIA","owner_display_name":"GRANDE ALICIA","owner_url":"/insider/0001402652","role":"Officer (VP, Treasurer and CFO)","role_mark":"O","role_mark_label":"Officer (VP, Treasurer and CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP, Treasurer and CFO","security_title":"Common Stock, par value $0.001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":60000.0,"shares_display":"60,000","price_per_share":15.768,"price_display":"15.77","price_state":"stated","total_value":946080.0,"total_display":"946,080.00","total_whole":"946,080","shares_owned_after":147442.0,"shares_owned_after_display":"147,442","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-11-15","filed_date":"2022-11-17","scope":"insider"},{"id":6604882,"accession":"0001161697-22-000482","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001161697-22-000482","line_url":"/filing/0001161697-22-000482#line-1","is_derivative":false,"issuer_cik":"0001369568","issuer_name":"CATALYST PHARMACEUTICALS, INC.","issuer_ticker":"CPRX","issuer_name_source":null,"issuer_url":"/issuer/0001369568","owner_cik":"0001402652","owner_name":"GRANDE ALICIA","owner_display_name":"GRANDE ALICIA","owner_url":"/insider/0001402652","role":"Officer (VP, Treasurer and CFO)","role_mark":"O","role_mark_label":"Officer (VP, Treasurer and CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP, Treasurer and CFO","security_title":"Common Stock, par value $0.001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":60000.0,"shares_display":"60,000","price_per_share":11.899,"price_display":"11.90","price_state":"stated","total_value":713940.0,"total_display":"713,940.00","total_whole":"713,940","shares_owned_after":207442.0,"shares_owned_after_display":"207,442","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-09-23","filed_date":"2022-09-26","scope":"insider"},{"id":6293410,"accession":"0001161697-22-000479","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001161697-22-000479","line_url":"/filing/0001161697-22-000479#line-1","is_derivative":false,"issuer_cik":"0001369568","issuer_name":"CATALYST PHARMACEUTICALS, INC.","issuer_ticker":"CPRX","issuer_name_source":null,"issuer_url":"/issuer/0001369568","owner_cik":"0001402652","owner_name":"GRANDE ALICIA","owner_display_name":"GRANDE ALICIA","owner_url":"/insider/0001402652","role":"Officer (VP, Treasurer and CFO)","role_mark":"O","role_mark_label":"Officer (VP, Treasurer and CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP, Treasurer and CFO","security_title":"Common Stock, par value $0.001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":90000.0,"shares_display":"90,000","price_per_share":13.496,"price_display":"13.50","price_state":"stated","total_value":1214640.0,"total_display":"1,214,640.00","total_whole":"1,214,640","shares_owned_after":267442.0,"shares_owned_after_display":"267,442","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-09-16","filed_date":"2022-09-20","scope":"insider"},{"id":6367083,"accession":"0001161697-22-000467","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001161697-22-000467","line_url":"/filing/0001161697-22-000467#line-1","is_derivative":false,"issuer_cik":"0001369568","issuer_name":"CATALYST PHARMACEUTICALS, INC.","issuer_ticker":"CPRX","issuer_name_source":null,"issuer_url":"/issuer/0001369568","owner_cik":"0001402652","owner_name":"GRANDE ALICIA","owner_display_name":"GRANDE ALICIA","owner_url":"/insider/0001402652","role":"Officer (VP, Treasurer and CFO)","role_mark":"O","role_mark_label":"Officer (VP, Treasurer and CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP, Treasurer and CFO","security_title":"Common Stock, par value $0.001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":50000.0,"shares_display":"50,000","price_per_share":15.573,"price_display":"15.57","price_state":"stated","total_value":778650.0,"total_display":"778,650.00","total_whole":"778,650","shares_owned_after":357442.0,"shares_owned_after_display":"357,442","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-09-14","filed_date":"2022-09-16","scope":"insider"},{"id":6128580,"accession":"0001161697-22-000425","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001161697-22-000425","line_url":"/filing/0001161697-22-000425","is_derivative":false,"issuer_cik":"0001369568","issuer_name":"CATALYST PHARMACEUTICALS, INC.","issuer_ticker":"CPRX","issuer_name_source":null,"issuer_url":"/issuer/0001369568","owner_cik":"0001402652","owner_name":"GRANDE ALICIA","owner_display_name":"GRANDE ALICIA","owner_url":"/insider/0001402652","role":"Officer (VP, Treasurer and CFO)","role_mark":"O","role_mark_label":"Officer (VP, Treasurer and CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP, Treasurer and CFO","security_title":"Common Stock, par value $0.001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":57000.0,"shares_display":"57,000","price_per_share":14.20280701754386,"price_display":"14.20","price_state":"stated","total_value":809560.0,"total_display":"809,560.00","total_whole":"809,560","shares_owned_after":424442.0,"shares_owned_after_display":"424,442","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-08-29","filed_date":"2022-08-30","scope":"insider","n_lines":3},{"id":6128577,"accession":"0001161697-22-000425","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001161697-22-000425","line_url":"/filing/0001161697-22-000425#line-1","is_derivative":false,"issuer_cik":"0001369568","issuer_name":"CATALYST PHARMACEUTICALS, INC.","issuer_ticker":"CPRX","issuer_name_source":null,"issuer_url":"/issuer/0001369568","owner_cik":"0001402652","owner_name":"GRANDE ALICIA","owner_display_name":"GRANDE ALICIA","owner_url":"/insider/0001402652","role":"Officer (VP, Treasurer and CFO)","role_mark":"O","role_mark_label":"Officer (VP, Treasurer and CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP, Treasurer and CFO","security_title":"Common Stock, par value $0.001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11095.0,"shares_display":"11,095","price_per_share":14.4,"price_display":"14.40","price_state":"stated","total_value":159768.0,"total_display":"159,768.00","total_whole":"159,768","shares_owned_after":464442.0,"shares_owned_after_display":"464,442","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-08-26","filed_date":"2022-08-30","scope":"insider"},{"id":6445410,"accession":"0001161697-22-000398","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001161697-22-000398","line_url":"/filing/0001161697-22-000398#line-6","is_derivative":false,"issuer_cik":"0001369568","issuer_name":"CATALYST PHARMACEUTICALS, INC.","issuer_ticker":"CPRX","issuer_name_source":null,"issuer_url":"/issuer/0001369568","owner_cik":"0001402652","owner_name":"GRANDE ALICIA","owner_display_name":"GRANDE ALICIA","owner_url":"/insider/0001402652","role":"Officer (VP, Treasurer and CFO)","role_mark":"O","role_mark_label":"Officer (VP, Treasurer and CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP, Treasurer and CFO","security_title":"Common Stock, par value $0.001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":19259.0,"shares_display":"19,259","price_per_share":13.7,"price_display":"13.70","price_state":"stated","total_value":263848.3,"total_display":"263,848.30","total_whole":"263,848","shares_owned_after":475537.0,"shares_owned_after_display":"475,537","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-08-18","filed_date":"2022-08-19","scope":"insider"},{"id":6445403,"accession":"0001161697-22-000398","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001161697-22-000398","line_url":"/filing/0001161697-22-000398","is_derivative":false,"issuer_cik":"0001369568","issuer_name":"CATALYST PHARMACEUTICALS, INC.","issuer_ticker":"CPRX","issuer_name_source":null,"issuer_url":"/issuer/0001369568","owner_cik":"0001402652","owner_name":"GRANDE ALICIA","owner_display_name":"GRANDE ALICIA","owner_url":"/insider/0001402652","role":"Officer (VP, Treasurer and CFO)","role_mark":"O","role_mark_label":"Officer (VP, Treasurer and CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP, Treasurer and CFO","security_title":"Common stock, par value $0.001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":130741.0,"shares_display":"130,741","price_per_share":13.856670709264883,"price_display":"13.86","price_state":"stated","total_value":1811634.9852,"total_display":"1,811,634.99","total_whole":"1,811,635","shares_owned_after":475537.0,"shares_owned_after_display":"475,537","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-08-17","filed_date":"2022-08-19","scope":"insider","n_lines":2},{"id":5111368,"accession":"0001161697-21-000393","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001161697-21-000393","line_url":"/filing/0001161697-21-000393#line-4","is_derivative":false,"issuer_cik":"0001369568","issuer_name":"CATALYST PHARMACEUTICALS, INC.","issuer_ticker":"CPRX","issuer_name_source":null,"issuer_url":"/issuer/0001369568","owner_cik":"0001402652","owner_name":"GRANDE ALICIA","owner_display_name":"GRANDE ALICIA","owner_url":"/insider/0001402652","role":"Officer (VP, Treasurer and CFO)","role_mark":"O","role_mark_label":"Officer (VP, Treasurer and CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP, Treasurer and CFO","security_title":"Common stock, par value $0.001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13000.0,"shares_display":"13,000","price_per_share":5.683,"price_display":"5.68","price_state":"stated","total_value":73879.0,"total_display":"73,879.00","total_whole":"73,879","shares_owned_after":464441.0,"shares_owned_after_display":"464,441","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-08-18","filed_date":"2021-08-19","scope":"insider"},{"id":5111360,"accession":"0001161697-21-000393","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001161697-21-000393","line_url":"/filing/0001161697-21-000393#line-2","is_derivative":false,"issuer_cik":"0001369568","issuer_name":"CATALYST PHARMACEUTICALS, INC.","issuer_ticker":"CPRX","issuer_name_source":null,"issuer_url":"/issuer/0001369568","owner_cik":"0001402652","owner_name":"GRANDE ALICIA","owner_display_name":"GRANDE ALICIA","owner_url":"/insider/0001402652","role":"Officer (VP, Treasurer and CFO)","role_mark":"O","role_mark_label":"Officer (VP, Treasurer and CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP, Treasurer and CFO","security_title":"Common stock, par value $0.001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100000.0,"shares_display":"100,000","price_per_share":5.669,"price_display":"5.67","price_state":"stated","total_value":566900.0,"total_display":"566,900.00","total_whole":"566,900","shares_owned_after":407441.0,"shares_owned_after_display":"407,441","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-08-17","filed_date":"2021-08-19","scope":"insider"},{"id":2296015,"accession":"0001161697-12-000525","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001161697-12-000525","line_url":"/filing/0001161697-12-000525","is_derivative":false,"issuer_cik":"0001369568","issuer_name":"CATALYST PHARMACEUTICAL PARTNERS, INC.","issuer_ticker":"CPRX","issuer_name_source":null,"issuer_url":"/issuer/0001369568","owner_cik":"0001402652","owner_name":"GRANDE ALICIA","owner_display_name":"GRANDE ALICIA","owner_url":"/insider/0001402652","role":"Officer (VP, Treasurer and CFO)","role_mark":"O","role_mark_label":"Officer (VP, Treasurer and CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP, Treasurer and CFO","security_title":"Common Stock, par value $0.001 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":20000.0,"shares_display":"20,000","price_per_share":0.549,"price_display":"0.55","price_state":"stated","total_value":10980.0,"total_display":"10,980.00","total_whole":"10,980","shares_owned_after":66346.0,"shares_owned_after_display":"66,346","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-07-03","filed_date":"2012-07-05","scope":"insider","n_lines":2},{"id":3473553,"accession":"0001161697-12-000437","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001161697-12-000437","line_url":"/filing/0001161697-12-000437#line-1","is_derivative":false,"issuer_cik":"0001369568","issuer_name":"CATALYST PHARMACEUTICAL PARTNERS, INC.","issuer_ticker":"CPRX","issuer_name_source":null,"issuer_url":"/issuer/0001369568","owner_cik":"0001402652","owner_name":"GRANDE ALICIA","owner_display_name":"GRANDE ALICIA","owner_url":"/insider/0001402652","role":"Officer (VP, Treasurer and CFO)","role_mark":"O","role_mark_label":"Officer (VP, Treasurer and CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP, Treasurer and CFO","security_title":"Common Stock, par value $0.001 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":17300.0,"shares_display":"17,300","price_per_share":0.57,"price_display":"0.57","price_state":"stated","total_value":9861.0,"total_display":"9,861.00","total_whole":"9,861","shares_owned_after":46346.0,"shares_owned_after_display":"46,346","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-05-30","filed_date":"2012-05-31","scope":"insider"},{"id":6007697,"accession":"0001181431-09-053082","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001181431-09-053082","line_url":"/filing/0001181431-09-053082#line-2","is_derivative":false,"issuer_cik":"0001369568","issuer_name":"Catalyst Pharmaceutical Partners, Inc.","issuer_ticker":"CPRX","issuer_name_source":null,"issuer_url":"/issuer/0001369568","owner_cik":"0001402652","owner_name":"GRANDE ALICIA","owner_display_name":"GRANDE ALICIA","owner_url":"/insider/0001402652","role":"Officer (Controller & CAO)","role_mark":"O","role_mark_label":"Officer (Controller & CAO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Controller & CAO","security_title":"Common Stock, par value $0.001 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":4200.0,"shares_display":"4,200","price_per_share":0.65,"price_display":"0.65","price_state":"stated","total_value":2730.0,"total_display":"2,730.00","total_whole":"2,730","shares_owned_after":24046.0,"shares_owned_after_display":"24,046","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-11-19","filed_date":"2009-11-20","scope":"insider"},{"id":6007695,"accession":"0001181431-09-053082","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-09-053082","line_url":"/filing/0001181431-09-053082#line-1","is_derivative":false,"issuer_cik":"0001369568","issuer_name":"Catalyst Pharmaceutical Partners, Inc.","issuer_ticker":"CPRX","issuer_name_source":null,"issuer_url":"/issuer/0001369568","owner_cik":"0001402652","owner_name":"GRANDE ALICIA","owner_display_name":"GRANDE ALICIA","owner_url":"/insider/0001402652","role":"Officer (Controller & CAO)","role_mark":"O","role_mark_label":"Officer (Controller & CAO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Controller & CAO","security_title":"Common Stock, par value $0.001 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":0.65,"price_display":"0.65","price_state":"stated","total_value":3250.0,"total_display":"3,250.00","total_whole":"3,250","shares_owned_after":19846.0,"shares_owned_after_display":"19,846","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-11-18","filed_date":"2009-11-20","scope":"insider"},{"id":3484863,"accession":"0001161697-08-001289","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001161697-08-001289","line_url":"/filing/0001161697-08-001289#line-2","is_derivative":false,"issuer_cik":"0001369568","issuer_name":"Catalyst Pharmaceutical Partners, Inc.","issuer_ticker":"CPRX","issuer_name_source":null,"issuer_url":"/issuer/0001369568","owner_cik":"0001402652","owner_name":"GRANDE ALICIA","owner_display_name":"GRANDE ALICIA","owner_url":"/insider/0001402652","role":"Officer (Chief Accounting Officer)","role_mark":"O","role_mark_label":"Officer (Chief Accounting Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Accounting Officer","security_title":"Common Stock, par value $0.001 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2500.0,"shares_display":"2,500","price_per_share":1.85,"price_display":"1.85","price_state":"stated","total_value":4625.0,"total_display":"4,625.00","total_whole":"4,625","shares_owned_after":9846.0,"shares_owned_after_display":"9,846","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-11-25","filed_date":"2008-11-26","scope":"insider"},{"id":3484859,"accession":"0001161697-08-001289","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001161697-08-001289","line_url":"/filing/0001161697-08-001289#line-1","is_derivative":false,"issuer_cik":"0001369568","issuer_name":"Catalyst Pharmaceutical Partners, Inc.","issuer_ticker":"CPRX","issuer_name_source":null,"issuer_url":"/issuer/0001369568","owner_cik":"0001402652","owner_name":"GRANDE ALICIA","owner_display_name":"GRANDE ALICIA","owner_url":"/insider/0001402652","role":"Officer (Chief Accounting Officer)","role_mark":"O","role_mark_label":"Officer (Chief Accounting Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Accounting Officer","security_title":"Common Stock, par value $0.001 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":1.85,"price_display":"1.85","price_state":"stated","total_value":1850.0,"total_display":"1,850.00","total_whole":"1,850","shares_owned_after":7346.0,"shares_owned_after_display":"7,346","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-11-24","filed_date":"2008-11-26","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":34,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":7,"open_market":true},{"code":"S","label":"Open-market sale","n":27,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":34},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001369568","name":"CATALYST PHARMACEUTICALS, INC.","url":"/issuer/0001369568","role":"Officer (VP, Treasurer and CFO)","n_filings":15,"first_seen":"2008-11-26","last_seen":"2023-12-12"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001402652","retrieved_at":"2026-08-23T05:35:24+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}